New hope for tough pancreatic tumors: scientists test stronger Radiation-Chemo combo
NCT ID NCT02207465
Summary
This early-stage study is testing a new treatment combination for pancreatic cancer that cannot be easily removed by surgery. Doctors are carefully increasing the doses of a chemotherapy drug (nab-paclitaxel) and radiation therapy together to see if it can better control the tumor. The goal is to find the safest and most effective dose to help patients live longer by keeping the cancer from growing locally.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Chester County Hospital
West Chester, Pennsylvania, 19380, United States
Conditions
Explore the condition pages connected to this study.